Medtronic Announces Executive & Board Changes
Ticker: MDT · Form: 8-K · Filed: Jun 4, 2024 · CIK: 1613103
| Field | Detail |
|---|---|
| Company | Medtronic PLC (MDT) |
| Form Type | 8-K |
| Filed Date | Jun 4, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: executive-changes, board-of-directors, governance
Related Tickers: MDT
TL;DR
Medtronic shakes up board and execs, effective June 1st.
AI Summary
Medtronic plc announced on June 4, 2024, changes in its executive team and board of directors, effective June 1, 2024. Specifically, Robert L. Taiclet has been appointed as a new Class III Director, and the company has also updated its compensatory arrangements for certain officers.
Why It Matters
Changes in board composition and executive roles can signal shifts in company strategy or governance, impacting investor confidence and future performance.
Risk Assessment
Risk Level: low — The filing details routine corporate governance changes and executive appointments, which typically carry low immediate risk.
Key Players & Entities
- Medtronic plc (company) — Filing company
- Robert L. Taiclet (person) — Newly appointed Class III Director
- June 1, 2024 (date) — Effective date of changes
- June 4, 2024 (date) — Filing date
FAQ
Who has been appointed as a new director at Medtronic plc?
Robert L. Taiclet has been appointed as a new Class III Director.
When were the announced changes effective?
The changes were effective as of June 1, 2024.
What type of filing is this for Medtronic plc?
This is a Form 8-K filing.
What are the main items covered in this 8-K filing?
The filing covers the departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers.
What is Medtronic plc's standard industrial classification?
Medtronic plc's standard industrial classification is ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845].
Filing Stats: 572 words · 2 min read · ~2 pages · Grade level 9.3 · Accepted 2024-06-04 16:37:54
Key Financial Figures
- $0.0001 — registered Ordinary shares, par value $0.0001 per share MDT New York Stock Exchange
Filing Documents
- mdt-20240601.htm (8-K) — 50KB
- 0001613103-24-000064.txt ( ) — 308KB
- mdt-20240601.xsd (EX-101.SCH) — 6KB
- mdt-20240601_def.xml (EX-101.DEF) — 22KB
- mdt-20240601_lab.xml (EX-101.LAB) — 45KB
- mdt-20240601_pre.xml (EX-101.PRE) — 24KB
- mdt-20240601_htm.xml (XML) — 15KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Medtronic plc By /s/ Ivan K. Fong Date: June 4, 2024 Ivan K. Fong Executive Vice President, General Counsel and Secretary